What is NDC 85437-093?

85437-093 is the product NDC for Auranofin, Auranofin 3 mg/1 capsule, listed with the FDA by Coral Way Pharma, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Coral Way Pharma, LLC, NDC labeler code 85437. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Auranofin?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Auranofin NDC 85437-093 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)85437-093Labeler and product segments. Claims need a package NDC.

Product NDC at billing width85437-0093Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
85437-093-06	85437009306	60 CAPSULE in 1 BOTTLE (85437-093-06)Marketed from Oct 29, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Auranofin
Generic name (nonproprietary): auranofin
Active ingredients: Auranofin — 3 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Coral Way Pharma, LLCNDC labeler code 85437
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 018689
Marketing start: Oct 29, 2025
Listing expires: Dec 31, 2026
Identifiers: Product ID 85437-093_42776e01-ac39-5aa4-e063-6294a90a99e9SPL ID 42776e01-ac39-5aa4-e063-6294a90a99e9SPL set ID d688978b-8b91-4377-9f1d-89b805f5747cRxCUI 197386UNII 3H04W2810V

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N485437009306 followed by a unit qualifier and the quantity

Package 85437-0093-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 31, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Auranofin Capsules (auranofin) is indicated in the management of adults with active classical or definite rheumatoid arthritis (ARA criteria) who have had an insufficient therapeutic response to, or are intolerant of, an adequate trial of full doses of one or more nonsteroidal anti-inflammatory drugs. Auranofin Capsules should be added to a comprehensive baseline program, including non-drug therapies. Unlike anti-inflammatory drugs, Auranofin Capsules does not produce an immediate response. Therapeutic effects may be seen after three to four months of treatment, although improvement has not been seen in some patients before six months. When cartilage and bone damage has…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 85437-093

What is NDC 85437-093?: 85437-093 is the product NDC for Auranofin, Auranofin 3 mg/1 capsule, listed with the FDA by Coral Way Pharma, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Auranofin.
What is the active ingredient?: Auranofin.
Who is the labeler?: Coral Way Pharma, LLC, NDC labeler code 85437. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Auranofin?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under NDA 018689

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 018689
Product	Strength	Form · route	Labeler	Product NDC
Ridauraauranofin	Auranofin 3 mg/1	CapsuleOral	Sebela Pharmaceuticals Inc.	54766-093